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Inducible chromatin priming is associated with the
establishment of immunological memory in T cells
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Abstract
Immunological memory is a defining feature of vertebrate physiol-
ogy, allowing rapid responses to repeat infections. However, the
molecular mechanisms required for its establishment and mainte-
nance remain poorly understood. Here, we demonstrated that the
first steps in the acquisition of T-cell memory occurred during the
initial activation phase of naïve T cells by an antigenic stimulus.
This event initiated extensive chromatin remodeling that repro-
grammed immune response genes toward a stably maintained
primed state, prior to terminal differentiation. Activation induced
the transcription factors NFAT and AP-1 which created thousands
of new DNase I-hypersensitive sites (DHSs), enabling ETS-1 and
RUNX1 recruitment to previously inaccessible sites. Significantly,
these DHSs remained stable long after activation ceased, were
preserved following replication, and were maintained in memory-
phenotype cells. We show that primed DHSs maintain regions of
active chromatin in the vicinity of inducible genes and enhancers
that regulate immune responses. We suggest that this priming
mechanism may contribute to immunological memory in T cells by
facilitating the induction of nearby inducible regulatory elements
in previously activated T cells.
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Introduction
Immunological memory plays a crucial role in maintaining the
mammalian immune response, enabling a rapid reaction to foreign
pathogens when they are re-encountered. Memory T cells (TM) arise
as a consequence of previous immune reactions and are primed to
efficiently upregulate key response genes when re-challenged, while
antigen-inexperienced naive T cells (TN) take much longer to
respond to the same stimuli (Rogers et al, 2000; Sprent & Surh,
2002). The initial activation of TN by antigen-presenting cells (APC)
involves an interaction of the T-cell receptor (TCR) with a specific
antigen bound to the major histocompatibility complex on the APC.
This occurs in parallel with additional interactions with co-stimulatory
molecules, such as CD28 (Brownlie & Zamoyska, 2013). These
responses trigger protein kinase and calcineurin signaling pathways
which activate inducible transcription factors (TFs) such as AP-1,
NFAT, and NF-jB. These TFs, together with preexisting develop-
mentally regulated TFs such as RUNX1 and ETS-1, are required for
the expression of inducible cytokines and cytolytic molecules which
function within a complex network of immune cells to eliminate
infections. The work of numerous laboratories has led to a detailed
understanding of the Ca2+-dependent activation of NFAT and the
kinase-dependent activation of AP-1 and NF-jB, and the roles they
play in creating inducible DNase I-hypersensitive sites (DHSs) and
in the regulation of TCR-inducible genes such as IL2, IL3, and CSF2
(Hogan et al, 2003; Johnson et al, 2004). ETS-1 and RUNX1 also
play wider important roles throughout T-cell development and acti-
vation (Muthusamy et al, 1995; Telfer & Rothenberg, 2001; Egawa
et al, 2007; Hollenhorst et al, 2009).
When stimulated for the first time, TN undergo a protracted
process of internal reorganization taking 1–2 days, during which
they transform from a quiescent spore-like state to actively prolifer-
ating T blast cells (TB) (Zhao et al, 1998). During this period, the
nucleus undergoes extensive Brg1-dependent chromatin remodeling
and increases 5- to 10-fold in volume. Once formed, TB are capable
of undergoing many rounds of proliferation in the absence of further
TCR stimulation, using IL-2 as a growth factor. In the absence of
TCR signaling, these recently activated TB cells no longer express
the inducible cytokines and cytolytic molecules normally associated
with fully activated T cells. However, upon re-stimulation, TB
respond like TM and rapidly react to TCR signaling (Mirabella et al,
2010). For example, we previously showed that in TB cells, a NFAT-
dependent DHS at the inducible CSF2 enhancer can be formed
within just 20 min of stimulation (Johnson et al, 2004). In vivo, the
blast transformation phase is typically followed by further differenti-
ation to effector cells such as Th1 and Th2 cells, according to the
type of infection. Following clonal expansion and pathogen
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clearance, the effector T-cell population contracts, leaving a small
proportion of surviving cells. These cells return to the quiescent
state as TM, while retaining some of the properties of TB.
Several studies have compared steady-state levels of chromatin
modifications and gene expression and identified differences
between TN and TM in the balance between Trithorax and
Polycomb-regulated chromatin domains of histone methylation
(Yamashita et al, 2004; Araki et al, 2009; Nakayama & Yamashita,
2009; Russ et al, 2014; Seumois et al, 2014; Crompton et al, 2015),
in domains of histone acetylation (Araki et al, 2008), and in DNA
methylation (Hashimoto et al, 2013; Komori et al, 2015). However,
while these domains can correlate with differences in steady-state
mRNA levels in resting TN and TM, their relevance to inducible
gene expression remains largely unexplored. Furthermore, no
mechanisms have yet been described to account for how these
domains are created and maintained.
The molecular mechanisms responsible for the disparity between
TN and TM remain unclear, as there are no obvious candidates for
TM-specific TFs. There is, however, ample evidence that epigenetic
mechanisms play a role in maintaining T-cell differentiation and
memory (Rothenberg & Zhang, 2012). It has long been known that
terminal T-cell differentiation to Th1 or Th2 T cells is accompanied
by the gain of DHSs at specific cytokine gene loci (Agarwal & Rao,
1998), in parallel with the induction of Th1- and Th2-specific factors
such as TBX21 and GATA-3. However, many of the DHSs acquired
during the process of activation and differentiation are shared across
different classes of differentiated T cells, and the significance of
many of these sites remains unclear. For example, the Th2-specific
Il4 gene is associated with several DHSs in the Il4/Rad50 locus that
are present in both Th1 and Th2 cells, but absent in naı¨ve T cells
(Agarwal & Rao, 1998; Fields et al, 2004). The Il10 gene is similarly
regulated by both Th2-specific DHSs, and DHSs which are also
present in undifferentiated T blast cells or in Th1 cells (Jones &
Flavell, 2005). Regulatory T cells (Treg) represent another class of
differentiated T cells which acquire a specific set of DHSs that are
absent in TN. Differentiation to Treg is driven by the TF FOXP3, but
also in this case, many of the Treg-specific DHSs are acquired prior
to terminal differentiation to Treg (Samstein et al, 2012). Taken
together, these studies suggest that T-cell activation may create a
permissive state at many loci that renders them receptive to any of
the various subsequent differentiation-inducing signals they may
encounter which are mediated by lineage-specific factors that
include FOXP3, TBX21, and GATA-3.
In our previous studies of the human IL3/CSF2 locus, we investi-
gated the properties of regulatory elements that control the activa-
tion of these two highly inducible cytokine genes in T cells. Similar
to the above studies, we identified two distinct classes of DHS that
were acquired at different stages of T-cell differentiation and activa-
tion (Mirabella et al, 2010; Baxter et al, 2012). One class existed as
stably maintained DHSs that were absent in the thymus and in naı¨ve
T cells, and were formed during the process of T blast cell transfor-
mation, when T cells become activated via TCR signaling for the
first time. Once formed, these primed DHS (pDHSs) were preserved
for many cell cycles in the absence of continued TCR signaling.
Furthermore, the pDHSs in this locus were detected in circulating
human memory T cells, suggesting that they are also temporally
stable for what might be months or years (Mirabella et al, 2010).
However, the function of these pDHSs remained unclear as they had
no detectable enhancer activity when measured by transient
transfection assays using reporter genes (Hawwari et al, 2002;
Baxter et al, 2012). In addition to these pDHSs, we also identified
several inducible DHSs (iDHSs) that appeared transiently in direct
response to activation of TCR signaling (Cockerill, 2004; Baxter
et al, 2012). Similar to iDHSs detected in other inducible genes in T
cells, such as Il4 (Fields et al, 2004) and Il10 (Jones & Flavell,
2005), the iDHSs in the IL3/CSF2 locus were associated with strong
inducible enhancer function in both transient transfection assays
and transgenic mice (Cockerill et al, 1999; Baxter et al, 2012).
In the current study, our aim was to globally identify and charac-
terize the regulatory elements and factors that maintain alternate
chromatin states and underpin the recall response characteristic of
both TM and TB. Our aim was to identify common mechanisms that
might be shared across all classes of T cells to establish a permissive
state that facilitates secondary responses in previously activated T
cells. We performed genomewide sequencing of DHSs (DNase-Seq)
and chromatin immunoprecipitation assays (ChIP-Seq) of TFs and
histone modifications in TN, TM, and TB before and after stimula-
tion. We identified over 2,000 pDHSs which were absent in TN but
present in both TM and TB and were shared by CD4
+ T helper cells
and CD8+ cytotoxic T cells. In actively dividing TB cells, many of
these pDHSs were stably bound by ETS-1 and RUNX1, which we
propose function to maintain chromatin priming. Upon re-stimulation,
they were also bound by AP-1 which we propose is required to both
establish priming and promote subsequent inducible responses.
Significantly, the pDHSs were embedded within islands of active
chromatin marked by H3K4me2 and H3K27ac which often encom-
passed inducible enhancers that could be activated in TB, but not in
TN. In contrast to some genes which are silenced in naı¨ve T cells by
the Polycomb-regulated H3K27me3 modification, the pDHSs we
identified were not marked by H3K27me3 in naı¨ve T cells.
We therefore propose a model whereby many inducible immune
response genes exist within inaccessible chromatin in TN cells until
they become primed toward an active chromatin state that is
permissive for rapid enhancer induction by NFAT and AP-1, and
accessible to additional differentiation-inducing TFs. Our model
provides a simple chromatin-based mechanism for maintaining the
priming of TM-specific regulatory elements using preexisting TFs
which might allow T cells to retain immunological memory without
the need for additional specific factors to silence genes in TN.
Results
To define the regulatory network establishing immunological
memory, we performed an integrated set of genome-wide analyses to
identify the DNA elements, TFs, co-activators, and histone modifi-
cations that correlate with a stable reprogrammed state in TM and TB.
Because we wanted to investigate global mechanisms of T-cell regu-
lation, we chose to examine naturally arising memory-phenotype cells
(TM) instead of TCR-specific T cells that may be restricted to a single
T-cell lineage and differentiation state. We first purified different
populations of CD4+ T helper cells and CD8+ cytotoxic T cells from
mice and then analyzed their responses to stimulation of TCR signal-
ing pathways. For this purpose, we used the C42 transgenic mouse
model which contains the intact human IL3/CSF2 locus encoding
IL-3 and GM-CSF (Fig 1A) (Mirabella et al, 2010; Baxter et al, 2012).
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IL3 and CSF2 are prototypical cytokine genes that are efficiently
induced in TM or TB, but not in TN or thymocytes (Mirabella et al,
2010). This locus has been intensively studied as a model for defin-
ing inducible mechanisms of enhancer activation in TB (Johnson
et al, 2004; Bert et al, 2007; Baxter et al, 2012). Furthermore, this
locus contains DHSs which are already known to exist in TB and TM,
but not in thymocytes or TN (Mirabella et al, 2010; Baxter et al,
2012), providing obvious candidates for a study of DNA elements
that maintain memory and at the same time allowed us to examine
whether the actual mechanisms of memory maintenance were
conserved between human and mouse.
We prepared subsets of resting T lymphocytes from C42 mouse
spleens and further purified TN and TM. Actively proliferating TB
were prepared by stimulation of CD4 and CD8 T cells for 2 days with
the lectin concanavalin A (ConA) to activate surface receptors,
followed by a period of rapid proliferation for 2–3 days in the
presence of IL-2 (Fig 1B). We confirmed that the process of ConA
stimulation was sufficient to rapidly induce the AP-1 family gene Fos.
However, the human CSF2 transgene and the mouse chemokine (C-C
motif) ligand1 gene (Ccl1) were induced much more slowly over a
period of 16 h (Appendix Fig S1A). We also used flow cytometry
(FACS) to demonstrate that the bulk of each population of CD4 T cells
had the expected properties: (i) TN were predominantly CD62L
+ cells
lacking the activation markers CD44 and CD25, (ii) TM were predomi-
nantly memory-phenotype cells expressing CD44 but lacking CD62L
and CD25, thereby resembling effector memory T cells, and (iii) TB
predominantly expressed the activation markers CD25 and CD44,
consistent with activated effector T cells (Appendix Fig S1B).
Each population of T cells was then stimulated for 2 h with PMA
and the calcium ionophore A23187 (PMA/I) to activate TCR signal-
ing pathways that induce AP-1 and NFAT activity. By directly acti-
vating pathways downstream of the TCR, we ensured that we
investigated mechanisms directly associated with epigenetic and
transcriptional responses and not just differences in the expression
or function of molecules mediating signaling from the cell surface.
Analyses of mRNA expression for human IL3 and CSF2, as well as
mouse Il4 and Il10, confirmed that each gene was rapidly and
strongly induced by PMA/I in CD4 TB but not in TN cells (Fig 1C).
These experiments verified that inducible cytokine gene loci in TN
and TB stimulated by PMA/I provide a meaningful model for study-
ing the memory recall response. Both cell types expressed the
mRNA for NFAT and AP-1 family proteins at comparable levels
prior to stimulation. Following induction with PMA/I over a 2-h
time course, both TB and TN induced the mRNA to a similar level
albeit with slightly different kinetics (Fig EV1A). This demonstrated
that it was not just a difference in TF mRNA expression that distin-
guishes the responses of TB and TM cells from TN, but a differential
usage or processing of such factors.
The human IL-3/GM-CSF gene loci display specific DHSs in TM
and TB
To map all potentially active cis-regulatory elements in T cells from
C42 mice, we performed global DNase-Seq which identifies accessi-
ble regions of chromatin bound by transcription factors (Cockerill,
2011). Specific analyses of the region covered by the human IL3/
CSF2 transgene detected all of the DHSs previously defined by
conventional assays (Baxter et al, 2012), plus a previously unknown
cluster of DHSs downstream of CSF2 (Fig 1D). Many of these DHSs
had properties consistent with the class of regulatory element
defined above as pDHSs. The IL3 1.5-kb, 4.1-kb, 34-kb, and
41-kb pDHSs, and the CSF2 +30-kb DHS were all present in TB and
not in TN. CSF2 mRNA was also highly inducible in both TB and TM
but not in TN (Fig 1C and E). Furthermore, both the CSF2 +30-kb
and IL3 34-kb pDHSs were present in circulating human peripheral
blood CD4+ CD45RA memory-phenotype T cells, at a level indis-
tinguishable from C42 mouse TB, and were weak or absent in
human CD4+ CD45RA+ naive T cells (Fig 1F). These findings
suggest that pDHSs are (i) maintained in actively proliferating TB in
the absence of TCR signaling, and (ii) contribute to the long-term
maintenance of memory in non-dividing circulating TM. These anal-
yses also confirmed that preparation of TB by stimulation with ConA
gave an identical pattern of DHSs in the human IL3/CSF2 locus to
that seen previously for TB prepared by specific stimulation of the
TCR complex and CD28 (Baxter et al, 2012), thereby validating the
choice of our in vitro model.
To further define the features of the stably maintained pDHSs, we
performed ChIP-Seq assays for histone H3K4me2 and H3K27ac in
CD4TB. These active chromatin modifications are routinely used to
map active enhancer elements (Rivera & Ren, 2013). Within the
transgene, pDHSs resided within broad domains marked by both
H3K4me2 and H3K27ac specifically in TB (Fig 1D). In stimulated
CD4 TB (TB
+), we detected additional inducible DHSs (iDHSs) which
included the well-defined 37-kb and 4.5-kb IL3 enhancers and the
IL3 promoter, and novel iDHSs 25 and 28 kb downstream of CSF2.
Significantly, these iDHSs existed in close proximity to pDHSs and
zones of active chromatin modifications. Each of these iDHSs, plus
the iDHS at the 3-kb CSF2 enhancer, was highly inducible in TB but
Figure 1. Previously activated T cells stably maintain an extensive array of DHSs at the IL3/CSF2 locus.
A The 130-kb human IL3/CSF2 BAC transgene. The insulator (Ins) and enhancer elements (E) are shown as boxes.
B Steps in the route to T blast cell transformation and re-activation. Purified CD4+ or CD8+ T cells were activated with 2 lg/ml ConA for 40 h and then maintained
in IL-2 as TB. Cells were re-stimulated with 20 ng/ml PMA and 2 lM calcium ionophore (PMA/I).
C Inducible mRNA expression levels in CD4 TN and TB stimulated with PMA/I for the indicated times. mRNA levels were expressed relative to the levels of beta-2
microglobulin (B2m) with SEM. The number of replicates (n) for each is shown underneath.
D UCSC genome browser shot of the human IL3/CSF2 locus showing DNase-Seq and ChIP-Seq in CD4 TN and TB with (red) and without stimulation (black) with
PMA/I for 2 h, plus the ENCODE Jurkat T-cell DNase-Seq data (Thurman et al, 2012). Black arrows represent stable DHSs and red arrows are inducible DHSs, with
the distances in kilobases of the DHS from either the IL3 or CSF2 promoters.
E Human CSF2 mRNA expression in CD4 TN and CD4 TM stimulated for 2 h with PMA/I, expressed as in (C).
F Southern blot DNA hybridization analyses of DHSs in human TN and TM and C42 TB.
G, H Luciferase reporter gene assays in stimulated Jurkat T cells transfected with the pXPG plasmid containing the CSF2 (G) or IL3 (H) promoter alone or in combination
with the indicated pDHS and enhancer DNA regions as defined in (D). The IL3 4.1/1.5 construct contains a contiguous region spanning the IL3 promoter from
4.3 kb to +50 bp. The number of replicates (n) is shown below, and the error bars indicate SEM (G) or SD (H).
▸
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not in TN, consistent with a mechanism whereby the stable pDHSs
function to maintain chromatin spanning inducible enhancers in a
primed state that allows their rapid response to TCR signaling.
We have previously shown that the 4.1-kb, 34-kb, and 41-kb
pDHSs in the IL3 locus lack enhancer activity, whereas the 37-kb
iDHS is a powerful inducible enhancer (Hawwari et al, 2002; Baxter
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et al, 2012). We therefore hypothesized that the human IL3 34-kb
and 41-kb DHSs were representative of a distinct class of regula-
tory element that maintain stable zones of active chromatin, but
lack classical enhancer activity (Baxter et al, 2012). Consistent with
this idea, the CSF2 +22-kb and +30-kb pDHSs also lacked indepen-
dent enhancer activity when linked to the CSF2 promoter and tested
in reporter gene assays in stimulated Jurkat T cells (Fig 1G), while
in the same assay the +28-kb iDHS functioned as a classical indu-
cible enhancer which increased CSF2 promoter activity threefold.
However, although it was inactive on its own, the +30-kb pDHS
synergized with the +28-kb enhancer in the activation of the
promoter. In addition, a DNA segment that contains both the IL3
1.5-kb and 4.1-kb pDHSs similarly lacked enhancer activity in
the context of the IL3 promoter, just like the IL3 34-kb and 41-kb
pDHSs, and in marked contrast to the 37-kb iDHS (Fig 1H). Taken
together, these data suggested that the stable pDHSs are not
necessarily classical enhancers, but may aid the induction of indu-
cible enhancers in a natural context when T cells are re-stimulated.
Activation of the human IL3 locus is assisted by locus priming
Human Jurkat T cells display a pattern of DHSs at the IL3 locus that
closely resembles the state seen in TB (Fig 1D). To investigate the
potential function of pDHSs in the absence of classical enhancer
activity, we used CRISPR technology to specifically delete the
human IL3 34-kb pDHS from both alleles in Jurkat cells (Fig 2A).
Analyses of average mRNA levels revealed a substantial delay in the
activation of IL3, but not JUN, in 2 clones lacking the 34-kb pDHS
when compared to clones with an intact locus (Fig 2B and C). We
next employed a PCR-based chromatin accessibility assay to demon-
strate that the adjacent 37-kb IL3 enhancer iDHS had reduced
accessibility to DNase I in the clones where the 34-kb pDHS was
deleted, whereas no consistent differences were observed in the
active TBP promoter or in an inactive control region (Fig 2D). These
data are consistent with pDHSs functioning to facilitate inducible
enhancer activation by establishing permissive active chromatin
domains.
The human and mouse IL-3/GM-CSF gene loci share
conserved pDHSs
To investigate the formation of pDHSs on a global scale, we used
the DNase-Seq data to map DHSs throughout the mouse genome.
Figure EV1B shows a comparison of CD4 TN, TB, and TM and CD8
TN and TB across a 900-kb region of the mouse genome which
includes the Il3/Csf2 locus, the Il4/Il13/Il5 Th2 cytokine gene clus-
ter, plus several other unrelated genes. Shared DHSs present in all
samples served as useful internal controls to confirm that appropri-
ate scales were depicted and that equivalent levels of DNase diges-
tion were employed. Most DHSs were conserved between the
human and mouse Il3/Csf2 loci (Figs 1D and EV1B). Most impor-
tantly, we detected the same general pattern of pDHSs and iDHSs as
seen in the human locus in both CD4 TM, CD4, CD8 TB and TN, con-
firming the existence of a distinct class of TB/TM-specific pDHSs that
are stably maintained by memory-phenotype cells. This pattern was
highly reproducible because it was seen in 2 independent analyses
of CD4 TN and TB (Fig EV1B). The 900-kb window, shown in
Fig EV1B, plus many other ubiquitously active loci, was used to
set all browser tracks to equivalent levels of detection. The scales
used here, and in all the browser tracks depicted below, are shown
in Appendix Fig S2. Shown underneath are Venn diagrams depicting
overlaps between DHS peak sets detected for the most prominent
peaks for the three datasets where biological replicates were
available.
Previous studies observed that the promoters of a subset of
memory T-cell-specific genes were repressed by the Polycomb-
regulated modification H3K27me3 in naı¨ve T cells and thymocytes
(Nakayama & Yamashita, 2009). However, this is unlikely to be a
universal mechanism, as we showed previously that this was not
the case for the promoters of the inducible human IL3/CSF2 trans-
gene which also cannot be induced in the thymus (Mirabella et al,
2010). Consistent with this finding, our analyses of additional
published datasets (Wei et al, 2009; Russ et al, 2014) confirmed that
regions spanning the above TB-specific DHSs in the mouse genome
had only background levels of H3K27me3 in both CD4 and CD8 TN,
where these loci are inactive, and showed the same pattern as
differentiated Th2 cells (Fig EV1B).
Mouse T cells display thousands of memory T-cell-specific pDHSs
Our next goal was to identify the full complement of pDHSs and
iDHSs in mouse T cells. However, this is not a straightforward task
because gene regulatory elements are an extremely diverse popula-
tion that span a broad continuum of DNA elements with varying
degrees of similarity to either pDHSs or iDHSs. In order to define the
general properties of pDHSs and iDHSs, we first needed to identify
representative groups of the most enriched and most specific DHSs
within each subset.
We began by evaluating the different properties of DHSs in CD4
and CD8 TN and TB, and in CD4 TM to identify the most specific
DHSs within each population. To this end, the TM and TB DHS data-
sets were each separately ranked according to fold change of
DNase-Seq tag counts first for (i) CD4 TM relative to CD4 TN
(Fig 3A) and then for (ii) CD4 TB relative to CD4 TN (Fig 3B), and
data were plotted as density maps spanning a 2-kb window centered
on the peak summits. In Fig 3B, the TM data was also plotted
directly alongside the coordinates of the TB/TN comparison. Two
observations were noteworthy: (i) TB and TM shared many specific
DHSs that were absent in TN, highlighting the similarity between the
recently activated proliferating TB and the quiescent primary TM; (ii)
we reproducibly observed global enrichment of the same population
of DHSs in TB compared to TN for both CD4 and CD8 T cells when
all the data, including independent replicates of the CD4 TN and TB
samples, were plotted using the same ranking as used for the origi-
nal CD4 TN and TB data shown in Fig 3B (Fig EV2A). Overall, these
data suggest that CD4+ T helper cells and CD8+ cytotoxic T cells
utilize a common set of DHSs to maintain epigenetic priming in
previously activated T cells. It is likely that these sites become estab-
lished soon after cells first become activated, prior to terminal T-cell
differentiation to specific subtypes such as Th1 and Th2. The persis-
tence of pDHSs in CD4 TM raised the interesting possibility that they
may serve the additional purpose of enabling the rapid reactivation
of inducible genes in memory T cells.
To obtain mechanistic insights into global mechanisms of pDHS
formation, we identified the most prominent pDHSs by using the
analysis shown in Fig 3A to define peaks that were at least threefold
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enriched in CD4 TM relative to CD4 TN. After excluding minor peaks,
we selected a reproducible subset of 2,882 of the CD4 TM pDHSs
that were also present in the CD4 TB DHS dataset (Dataset EV1).
The majority of the 2,882 CD4 pDHSs were also present in the CD8
TB (2,382 = 83%) and the replicate CD4 TB (85%) datasets shown
in Fig EV2A. These 2,882 shared DHSs were then used as a repre-
sentative, but not necessarily all-encompassing, population of
pDHSs for our further analyses. The average DHS profiles for these
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Figure 2. Impaired induction of IL3 gene expression and enhancer DHS formation following deletion of a pDHS in human Jurkat T cells.
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B Average IL3 (upper) and JUN (lower) mRNA expression in the 34-kb/ clones A and B compared to the WT clones A and B stimulated for 2, 4, and 8 h with PMA/I.
mRNA levels were normalized first to GAPDH and then to the level of gene expression in untransfected Jurkat T cells. Values represent the average of two 34-kb/
and two WT clones from two independent experiments (n = 4) with SD.
C IL3 and JUN mRNA expression levels after 2 h of stimulation with PMA/I normalized as in (B). The standard error is shown from five independent experiments.
D Deletion of the 34-kb pDHS impairs induction of the iDHS at the 37-kb inducible enhancer. The 34-kb/ clones A and B, the WT clones A and B, and
untransfected Jurkat T cells were stimulated with PMA/I for 3 h. A range of DNase I concentrations were used to determine the chromatin accessibility of the 37-kb
iDHS in two independent clones, with values expressed relative to normal unstimulated Jurkat cells. Increased accessibility was detected by a reduction in signal
detected by qPCR. The active TBP promoter and an inactive region on Chr18 are used as controls. Independent experiments for the 34-kb/ and WT clones A and B
compared to the untransfected Jurkat T cells are shown in the upper and lower panels, respectively.
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pDHSs in CD4+ cells (Fig 3C) confirmed that they are strong DHSs
in both TM and TB but weak in TN. This was also true for the
average profiles of the 2,882 CD4 pDHSs in CD8 TN and TB, and in
replicate samples of CD4 TN and TB (Fig EV2B). As an internal
control for non-specific DHSs, we used a randomly selected subset
of 2,882 invariant DHSs which were confirmed as being present in
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Figure 3. Genomewide mapping identifies a class of DHSs restricted to previously activated T cells.
A Density maps depicting all DNase-Seq peaks in the order of increasing DNase-Seq tag count signal for CD4 TM compared to TN. On the right are the locations of the
defined subset of 2,882 pDHSs and the log2 TM/TN fold change in expression of the closest gene to the corresponding DHS.
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D Pie chart showing the genomic distribution of pDHSs.
E Average H3K4me2, H3K27ac, and BRD4 signal at 2,882 pDHSs.
F Plot of the log2 fold change in gene expression following 2 h PMA/I for CD4 TM compared to TN. 1,895 genes (black) have a log2 fold change of 1 or above in TM but
not TN.
G Distance and gene expression analyses. P-value represents v2 significance against randomly expected number of pDHSs within 25 kb of a TSS (method described in
Appendix).
ª 2016 The Authors The EMBO Journal
Sarah L Bevington et al T-cell activation leads to epigenetic priming The EMBO Journal
7
all three CD4 T-cell types (Fig 3C). The 2,882 pDHSs were mapped
back to the genome and consisted mainly of distal sites (83%) in
intergenic and intronic regions, with just 12% being within 1 kb of
a transcription start site (TSS) (Fig 3D).
We next measured the level of two enhancer-associated histone
modifications at all of the DHSs by ChIP-Seq. The enrichment of
H3K4me2 and H3K27ac in TN and TB was plotted for each of the
DHSs as density maps (Fig 3B). As observed for the pDHSs at the
human IL3/CSF2 locus (Fig 1D), the 2,882 pDHSs were marked with
H3K4me2 and H3K27ac only in TB and not TN (Fig 3B and E). We
also performed ChIP-Seq for the transcriptional activator BRD4,
which binds to acetylated histones and has been shown to maintain
binding during mitosis (Zhao et al, 2011), and found a strong
enrichment at pDHSs in TB (Fig 3B and E). In contrast, the average
profiles for H3K27me3 taken from published datasets (Wei et al,
2009; Russ et al, 2014) were essentially baseline across the pDHSs
in CD4 and CD8 TN, and in Th2 cells (Fig EV2B), suggesting that
these regions are not differentially regulated via loss of a repressive
histone modification.
Activated TB and TM express a common set of inducible genes
In parallel with the genomewide DNase-Seq and ChIP-Seq analyses,
we measured mRNA expression levels in duplicate in the different
CD4 cell types (TN, TB, TM) and in CD8 TN and TB by microarray
analysis in both untreated cells and cells after 2 h of stimulation
with PMA/I. The comparison of the fold induction for each gene in
CD4 TN and TB showed 1,895 TM-specific genes being at least
twofold induced in TM and less than twofold induced in TN (black
dots, Fig 3F, Dataset EV2). In addition, the average fold change
values confirmed that the 1,895 CD4 TM-specific induced genes were
upregulated in both CD4 TM and TB (Fig EV2C). However, there
was little difference in steady-state levels of mRNA among TN, TB,
and TM, with values actually being slightly lower in TM and TB
(Fig EV2D). Gene ontology analysis indicated that these 1,895
upregulated genes were generally associated with immune
responses and the activation of signaling pathways (Fig EV2E). In
addition to the genes discussed above, this included many immune
regulators such as the interleukins 9, 19, 20, 22, 27, and 31, recep-
tors for CSF-1, IL-1, IL-2, IL-12, IL-15, and IL-13, other genes in cyto-
kine or chemokine pathways such as Cxcl3, and Cxcl5, Cxcr3, Cxcr5,
Ccl2, Ccl19, Ccl24, Ccr2, Ccr6, Tnfrsf4 and Tnfrsf9, Tnfsf8, and genes
encoding the transcription factors NFIL3, NFATc1, and NFAT5. Note
that although Nfatc1 was only modestly induced in TB (Fig EV1A),
it was induced more strongly in TM than in TB (Fig EV2F).
To search for common patterns of differential mRNA expression
among the various T-cell subsets, we performed a clustering analy-
sis of correlation coefficients for the top 1% of genes showing the
highest variance between all the subsets (242 genes, Fig EV2G).
This revealed a common expression pattern shared by stimulated
CD4 TM, CD4 TB, and CD8 TB, whereas the patterns for stimulated
TN cells more closely resembled non-stimulated TN cells for both
CD4+ and CD8+ T cells. Interestingly, the basal pattern for CD4 TM
was more similar to CD4 TN than it was to the stimulated CD4 TM,
likely reflecting the resting proliferation status of these cells. These
observations are significant because they suggest that the presence
of 2,882 pDHSs has little impact on baseline levels of gene expres-
sion, consistent with Figs 3A and EV2D and the notions that (i) the
role of pDHSs is to regulate inducible, not basal gene expression,
and (ii) that pDHSs are not classical enhancers that activate genes in
the absence of stimulation. A direct comparison of mRNA values for
the genes nearest to the 2,882 pDHSs, and for the 1,895 inducible
genes identified in Fig 3F, also demonstrated that there was no
substantial difference in the expression of these genes in the absence
of stimulation in TN compared to TM (Appendix Fig S3).
Primed DHSs are located proximal to inducible genes carrying
inducible DHSs
To globally assess the role of pDHSs in regulating inducible gene
expression, we mapped the distances from the TSSs of the 1,895 TM-
specific inducible genes to the nearest pDHS. We identified 683
genes (Dataset EV3) that had a pDHS located within 150 kb of the
TSS of the induced gene, representing 23.7% of all pDHSs (Fig 3G).
This figure was higher compared to the number of similarly sized,
randomly generated coordinates (214/2,882, 7.4%), randomly
selected constitutive DHSs (223/2,882, 7.7%) and randomly selected
iDHSs (438/2,882, 15.2%) located within 150 kb of an inducible
gene. Remarkably, more than 200 of these 683 pDHSs were located
within just 25 kb of the start site (P ≤ 10324), indicating a strong
correlation between proximity to preexisting pDHSs and inducible
gene expression in memory T cells. Of the remaining inducible
genes, 91% did nevertheless contain a constitutive DHS within
150 kb.
To identify DNA elements controlling the induction of gene
expression, we mapped the inducible DHSs (iDHSs) throughout the
genome in CD4 TB which had been stimulated for 2 h with PMA/I
(TB
+). In parallel, we performed ChIP-Seq for H3K4me2, H3K27ac,
and BRD4. The two sets of DHS data were plotted as density maps
ranked according to the fold change of DNase-Seq tag counts for the
combined TB
+ and TB datasets (Fig 4A). This analysis revealed
several thousand iDHSs which were associated with steadily
increasing levels of H3K4me2 flanking the iDHSs, and increasing
levels of mRNA expression for the adjacent genes, suggesting that
many of these elements act as enhancers.
To identify and characterize iDHSs, we initially focused on the
top 15% of iDHSs and defined a population of 6,823 iDHSs that
were induced by at least 5.5-fold relative to CD4 TB (Fig 4A).
However, since the most highly induced peaks showed the strongest
correlation with changes in both H3K4me2 and mRNA expression,
we also performed a more stringent selection of the 1,217 strongest
iDHSs that were enriched by at least 11-fold (Dataset EV4). The
average DHS profiles for these 1,217 highly specific iDHSs con-
firmed that they were strictly inducible, present only in TB
+ and
TM
+ and not in the un-stimulated TB, TN, or TM (Fig 4B). However,
there was also a subset of 1,049 DHSs that were diminished by at
least fourfold after stimulation (dDHSs), and the inducible changes
in the average H3K27ac profiles of dDHSs suggested both a decrease
in the level of H3K27ac and a closing up of the nucleosome-free
regions at these sites (Fig 4C). This subset included 249 pDHSs,
suggesting that the chromatin encompassing pDHSs and iDHSs is
highly dynamic. In contrast, iDHSs became highly enriched for
H3K27ac, H3K4me2, and BRD4 specifically after the cells were
stimulated (Fig EV3A). Similar to the pDHSs, the 1,217 iDHSs were
located mainly in intragenic and intronic regions, with just 1.4%
being within 1 kb of a TSS (Fig 4D).
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We next investigated the potential significance of the iDHSs with
respect to gene expression and measured the distances from the
TSSs of the 1,895 TM-specific inducible genes (Fig 3F) to the nearest
iDHS (using the more inclusive 6,823 subset). Approximately 1,000
of the inducible genes had an iDHS within 150 kb of the TSS, and
nearly 500 of these elements were located within just 25 kb which
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was highly significant (P = 1092) (Fig 4E), further signifying a role
for the iDHSs as inducible enhancers of these genes. Consistent with
this finding, the most highly induced TM-specific genes were associ-
ated with the closest iDHSs, whereby the 48 genes that were
induced greater than 10-fold were on average within 10 kb of an
iDHS (Fig 4F) suggesting a role of these elements as enhancers.
We next addressed the question of the potential relationships
between pDHSs, iDHSs, and inducible genes by focusing on the 683
pDHSs which were within 150 kb of a TM-specific inducible gene
(Fig 3G) and measuring the distances between these pDHSs and the
closest iDHS (Fig 4G). Significantly, 587 (86%) of the 685 pDHSs
contained an iDHS within 150 kb, and 312 of these (46%) were
within just 25 kb (P = 10132). These data reinforce the view that
pDHSs function at close range to support inducible enhancer func-
tion. In addition, we found that the most highly induced genes also
displayed the shortest distances between the pDHSs and iDHSs
(Fig 4H). Hence, the 54 genes that were induced at least sixfold
featured a pDHS located within an average of 15 kb of an iDHS.
Significantly, 187 of these 312 loci also carried an iDHS that was
located within 25 kb of the TSS. Gene ontology analysis of these
187 genes showed a highly significant association with immune
responses and the activation of signaling pathways (Fig EV3B)
including immune regulators such as Il3, Il4, Il31, Il15ra, Il1rl1,
Il18rap, Cxcr3, Ccr2, Tnfrsf4, Tnfrsf9, Tnfsf8, Tnfaip8, Itga3, Itgav,
Alcam, Mpzl2, Lpar3, Notch1, Icos, Map3k5, and Fyn, and key TF
genes such as Rela, Nfil3, and Nfatc1.
To further investigate the potential significance of pDHSs, we
plotted their positions relative to iDHSs located within 150 kb of a
promoter of an inducible TM-specific gene (Appendix Fig S3C). This
confirmed the strong trend for pDHSs to be located close to iDHSs,
independently of the distances of these DHSs from the promoter.
To provide additional examples for loci that utilize pDHSs and
iDHSs, we examined two other classic models of inducible cytokine
loci: the Th2 cytokine gene locus, encompassing Il4, Il13, and the
Th2 locus control region (LCR) (Lee et al, 2005) (Fig 4I), and the
Il10 locus (Jones & Flavell, 2005) (Fig EV3C). Similar to Il3 and
CSF2, Il4 and Il10 were specifically induced in TB and TM but not TN
(Figs 1C and EV3D) and contain multiple pDHSs and iDHSs which
were only detected in previously activated T cells (Figs 4I and
EV3C). The Th2 cytokine locus contains several TB-specific iDHSs,
including one 11.5 kb downstream of Il4, and one within the
Th2 LCR, which were each shown previously to function as enhan-
cers (Lee et al, 2001). Both of these iDHSs lie close to pDHSs in TB
and TM (Fig 4I). Like the pDHSs at the IL3/CSF2 locus (Fig 1D)
(Baxter et al, 2012), the Il4 +9-kb pDHS (defined by others as HS4)
also lacked independent enhancer function (Lee et al, 2001). A simi-
lar example is shown for Il10 (Fig EV3C) where an array of pDHSs
and iDHSs extends 30 kb upstream of the promoter specifically in
previously activated cells. The Il4 +11.5-kb and the Il10 24-kb
iDHSs are both included within primed regions having elevated
levels of H3K27ac and H3K4me2 in TB prior to stimulation. A paral-
lel analysis of published H3K27me3 datasets for Il4 and Il10 again
showed no prior enrichment for this modification in CD4 or CD8 TN
in regions that subsequently form TM-specific DHS during blast
cell transformation (Figs 4I and EV3C). However, there was a
TN-specific enrichment for H3K27me3 at the Il10 promoter, consistent
with this being a parallel mechanism of regulating the transition
from TN to TB and TM, but operating at a different class of regulatory
elements.
Primed DHSs bind constitutively expressed transcription factors
The 2,882 pDHSs created during T-cell blast cell transformation are
stably maintained in both dividing and non-dividing cells, without
any substantial change to the TF expression program. Therefore, a
key question is why the pDHSs remain open in TB and TM, while
the iDHSs are not maintained. To this end, we investigated which
transcription factors remained stably bound to pDHSs in the unstim-
ulated state by searching for enriched DNA motifs within the pDHSs
using HOMER (Heinz et al, 2013). The most enriched motifs corre-
sponded to the known consensus binding sequences for ETS and
RUNX family transcription factors, which were present in 44 and
47% of the targets, respectively (Fig 5A). Significantly, the ETS
motif identified here corresponds to the composite ETS/RUNX motif
to which these factors bind in a cooperative fashion in T cells
(Hollenhorst et al, 2009). To a lesser extent, pDHSs were also enriched
for motifs for inducible factors which respond to TCR and growth
factor signaling, including AP-1, IRF, and STAT family proteins. We
plotted the coordinates of the motifs back onto the DHSs, ordering
them as previously according to the DHS intensity fold change for
TB compared to TN (Fig 5B). Consistent with their known functions
throughout T-cell development, the RUNX and ETS motifs were
found both at TB-specific pDHSs and at constitutive DHSs shared by
TB and TN. In contrast, the motifs for AP-1 and STAT were predomi-
nantly found within the TB-specific DHSs. We also performed a
bootstrapping analysis which determined the statistical significance
Figure 4. iDHSs lie close to pDHSs and are associated with inducible genes.
A Density maps identifying iDHSs and showing DNase-Seq and H3K4me2 ChIP-Seq peaks in order of increasing DNase-Seq tag count signal for CD4 TB
+ compared to
TB cells. Also depicted are the locations of 6,823 major DHSs that are 5.5-fold induced and a subset of 1,217 of these iDHSs that are 11-fold induced. On the right is
the log2 TB
+/TB fold change in expression of the closest gene to the corresponding DHS.
B Average DNase I profiles of the 1,217 iDHSs in TN (+/ PMA/I) and TB (+/ PMA/I) (left), and in TM (+/ PMA/I) (right).
C Average DNase I and H3K27ac profiles of the 1,049 dDHSs in TN and TB (+/ PMA/I) which are fourfold diminished after stimulation.
D The genomic distribution of the 1,217 iDHSs.
E–H Barplots showing the number of TM-specific genes with an iDHS within 150 kb of the TSS (E); the median distances between the TSSs and the closest iDHS of the
TM-specific genes grouped according to the fold induction in TM after 2 h plus PMA/I compared to TM for genes which had a TSS < 1 Mb from an iDHS (F); the
number of TM-specific genes which have an iDHS within 150 kb of the 683 pDHSs (G); and the median distances from the closest pDHS to the closest iDHS
grouped according to the fold induction in TM after 2 h plus PMA/I compared to TM (H). P-values represent either v
2 significance against randomly expected
number of DHSs within 25 kb (F and H) or t-test significance against equally sized random DHSs (E and G). The methods used to calculate P-values are described
in the Appendix.
I UCSC genome browser shot of the Th2 Il4/Il13/Rad50 locus showing DNaseI-Seq and ChIP-Seq. Black and red arrows represent pDHSs and iDHSs, respectively. The
values above the arrows indicate the distance in kb from the Il4 promoter.
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of motif co-occurrence within 50 bp and observed that the ETS,
RUNX, STAT, GATA, and AP-1 motifs co-localized within the pDHSs
(Fig 6A) and most likely form interacting complexes.
To verify that the predicted TF motifs were occupied in vivo, we
performed ChIP-Seq to assess the levels of RUNX1 and ETS-1 bind-
ing to the DHSs in both TN and TB (Fig 5C). RUNX1 and ETS-1 bind-
ing was detected in both cell types at the shared DHSs. However,
binding of these factors to the pDHSs was restricted to TB (Fig 5C,
Appendix Fig S4). We excluded the idea that this result was caused
by increased RUNX1 and ETS-1 expression by examining gene
expression microarray data obtained from independently prepared
duplicates for each of the different cell types (Fig 6B) which
revealed similar levels of Runx1 and Ets1 mRNA in TN, TM, and TB.
We therefore hypothesized that additional inducible factors may be
required for the original genesis of the pDHSs and investigated the
levels of AP-1 binding by performing a JUNB ChIP-Seq assay.
Whereas very little basal level AP-1 binding was observed in TB
(Fig 5D), AP-1 binding was greatly increased in TB
+ after stimula-
tion, with high enrichment at the pDHSs, consistent with the
elevated AP-1 family mRNA levels (Fig EV1A) and the observed
Figure 5. pDHSs bind constitutively expressed transcription factors.
A De novo motifs enriched within 2,882 pDHSs determined using HOMER.
B Motif distribution in all DHSs ordered by increasing DNase-Seq tag count signal for CD4 TB relative to TN as in Fig 3B.
C DNase-Seq and RUNX1 and ETS-1 ChIP-Seq density maps showing the binding at the DHSs ordered as for (B), with average profiles of RUNX1 and ETS-1 binding to
the pDHSs in TB compared to TN shown below.
D JUNB ChIP-Seq in TB and TB
+ at the DHSs defined in TN and TB and ordered as in (B) with average profiles shown below.
E Patterns of RUNX1, ETS-1, and JUNB binding at RUNX, ETS, and AP-1 motifs at the Trpm6 locus.
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Figure 6. Co-association of ETS-1 and RUNX1 in pDHSs, and the role of RUNX1 in establishing priming.
A Hierarchical clustering of motif co-association enrichments in pDHSs. Z-scores represent enrichment of observed versus background co-associations computed in
1,000 randomly selected, chromatin-accessible regions.
B Log2 mRNA expression levels of Runx1, Ets1, and B2m in untreated and PMA/I-treated TN, TM, and TB from the microarray analysis.
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distribution of AP-1 motifs and ChIP peaks (Fig 5B, Appendix Fig
S4). We previously showed above that Fos mRNA was induced in
TN by ConA during blast cell transformation (Appendix Fig S1A).
These data support the view that AP-1 plays a role in the creation,
and subsequent reactivation, but not necessarily the steady-state
maintenance of pDHSs when much lower levels of at least Fos, Fosb,
and Jun mRNA are detected (Fig EV1A).
A specific example of TM-specific DHSs which contained the
predicted motifs and which showed enrichment by ChIP is shown in
Fig 5E depicting the transient receptor potential M6 (Trpm6) locus
which contained multiple TM/TB-specific DHSs. At the 3.2-kb and
+21-kb pDHSs, ChIP peaks were detected for RUNX1 and ETS-1 in
TB but not TN. Importantly, motifs for both these factors were
present within the hypersensitive region. At the 2.4-kb DHS, we
identified a RUNX motif, but no ETS motif, and this was reflected by
binding of RUNX1 but not ETS-1. Furthermore, at least 6 DHSs
within this locus encompass AP-1 motifs, and this was reflected by
specific JUNB binding in TB
+ and not in TB (Fig 5E).
Further efforts are needed to investigate functions of RUNX1 and
ETS-1, but this is a difficult issue to address because RUNX and ETS
proteins play important roles in many aspects of T-cell development
and function (Muthusamy et al, 1995; Telfer & Rothenberg, 2001;
Egawa et al, 2007). We began with a preliminary attempt at evaluat-
ing the roles of roles of RUNX1 in blast cell transformation and the
activation of inducible cytokine genes associated with pDHSs. For
this purpose, we prepared TB in the presence of either the inhibitor
Ro5-3335, which is reported to suppress RUNX1 function (Cunning-
ham et al, 2012), or with DMSO as a control. The inhibitor was
included during the activation of CD4 T cells by ConA, after which
the cells were cultured for 24 h with the inhibitor and IL-2.
However, the inhibitor greatly decreased the proportion of T cells
that survive the transformation process as live non-apoptotic cells
(Appendix Fig S5A). Nevertheless, when the inhibitor was removed
and the surviving live cells were stimulated, the residual effect of
the inhibitor was to suppress the induction of genes associated with
pDHSs (Il4, Il3, and CSF2) but not inducible genes or constitutive
genes believed to be independent of pDHSs (Tnf and Cd2)
(Appendix Fig S5B). These data are consistent with a requirement
for RUNX1 both in efficient blast cell transformation and in the
memory recall response.
RUNX and ETS motifs are occupied in TB and TM
To screen for potential additional factors without having to specu-
late on which antibody to use for ChIP assays, we employed our
recently developed Wellington algorithm (Piper et al, 2013) to
perform in silico DNase I footprinting on the DNase-Seq data from
TB. This algorithm statistically scores an imbalanced pattern of posi-
tive strand reads starting immediately 50 of the footprint and nega-
tive strand reads starting immediately 30 of the footprint, spanning
the binding site which is detected as a region with reduced reads.
The distribution of motifs detected by HOMER within these foot-
prints (Fig 7A) resembled that of motifs detected in the full-length
DHSs (Fig 5A), with RUNX and ETS the most prominent motifs,
accounting for more than half of all the predicted FPs. These were
followed by STAT motifs, representing another inducible factor
family potentially influencing pDHS formation. Figure 7B depicts
the relative DNase I profiles surrounding the FPs at each protected
RUNX, ETS, and STAT motif, showing the relative density of the
upper (red) versus lower (green) strand DNase I cuts. Equivalent
profiles are shown for footprinted AP-1, KLF, GATA, and RFX motifs
in Fig EV4A. FPs were ordered according to increasing occupancy
score with the most prominent patterns representing the best FPs
(Figs 7B and EV4A). Figures 7B and EV4A also show the average
DNase I profiles to illustrate the average cuts on each of the upper
(red) and lower (blue) strands centered about the motif. A similar
pattern of footprinted RUNX and ETS motifs was detected in TM
(Figs 7C and EV4B). An evaluation of the locations of footprinted
ETS and RUNX motifs revealed the same patterns of binding to
pDHSs in TM as was seen for the shared DHSs in TN (Fig EV4C).
Examples of occupied ETS and/or RUNX motifs in TB are shown for
2 pDHSs located 3.7 and 35 kb upstream of Ccl1 where binding of
both ETS-1 and RUNX1 was demonstrated by ChIP-Seq (Fig 7D). In
keeping with a role for the pDHSs in priming inducible gene expres-
sion, Ccl1 is upregulated more efficiently in TB and TM compared to
TN (Fig 7E). We also assayed the 3.7-kb and 35-kb pDHSs for
potential enhancer activity using the same assay system employed
above for testing the IL3 pDHSs. Similar to the IL3 pDHSs, these two
Ccl1 pDHSs had no significant enhancer activity in a transfection
assay (Fig 7F).
A much smaller percentage of pDHS FPs in non-stimulated TB
(4%) contained occupied AP-1 motifs compared to the number of
occupied RUNX and ETS motifs (Fig 7A). However, after stimula-
tion, protection at the AP-1 sites increased significantly in TB
+
(P = 1051, Fig 7G), consistent with the increased JUNB binding
(Fig 5D) that occurred upon treatment with PMA/I. This was
reflected by the distribution of footprint probability scores (Fig 7H).
Taken together, our ChIP and footprinting analyses suggest that
RUNX1 and ETS-1 cooperate with inducible factors such as AP-1 to
establish pDHS, and are important players in the maintenance of
open chromatin at these sites.
The ratio of inducible versus constitutive transcription factors
determines the properties of transient and stable DHS
We next addressed the question of what distinguished constitutive
pDHSs from the highly inducible iDHSs in TB
+. To this end, we
performed a de novo motif search using the subset of the 1,217 most
enriched iDHSs (Fig 8A). The distribution of motifs in the iDHSs in
TB
+ was markedly different to the pDHSs in TB as the pattern
was dominated by motifs for the inducible TFs AP-1 (58%) and
NFAT (56%). Many of these were composite NFAT/AP-1 motifs of
the type first described for the Il2 promoter and CSF2 enhancer
(Cockerill et al, 1995; Chen et al, 1998), and observed above in the
Trpm6 +23-kb iDHS (Fig 5E). The full-length composite NFAT/AP-1
motif depicted in Fig 8A was present in 34% of iDHSs, which were
also enriched with motifs for the inducible EGR and NF-jB families
of TFs. The enrichment of RUNX motifs was considerably lower in
iDHSs (12%) than in pDHSs (47%), and ETS motifs were not
enriched at all. These results were supported by bootstrapping anal-
yses of the statistical significance of motif co-occurrence within
50 bp, which demonstrated that inducible factors, but not ETS-1 or
RUNX1, co-localized in iDHSs (Fig EV5A).
The inducible TF motifs were mapped back onto the combined
TB and TB
+ DHS dataset (Fig 8B), once again ranked according to
the degree of DHS enrichment in TB
+ compared to TB as in Fig 4A.
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This revealed that the inducible TF binding sites were highly
enriched in the iDHSs and were located predominantly at their
centers. In contrast, the RUNX motifs and the RUNX1-bound DHSs
were divided between the shared DHSs and the iDHSs (Fig 8B and
C), similar to what was observed in the TB and TN analysis (Fig 5B).
However, the ChIP-Seq analyses showed that RUNX1 only bound to
the iDHSs after stimulation (Fig 8C). JUNB ChIP-Seq also confirmed
that AP-1 bound specifically to the inducible sites only when the
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cells were stimulated (Fig 8C). In contrast, the dDHSs that were lost
upon stimulation did not encompass AP-1 motifs. The inability to
recruit AP-1 most likely makes them susceptible to the effects of
chromatin remodeling that stems from other nearby DHSs which do
bind AP-1.
An example of the above patterns of TF binding is shown for the
Il10 locus (Fig 8D) where RUNX1 and JUNB bound to the 24-kb
and 30-kb iDHSs only in TB+. RUNX1 also bound to the 9-kb
and 26-kb pDHSs prior to stimulation, whereas AP-1 only bound
to these sites after treatment with PMA/I. A similar pattern of bind-
ing was observed at the Th2 cytokine gene locus (Fig EV5B).
Wellington FP analyses of the TB
+ DNase-Seq data revealed strong
footprints at the iDHSs, with AP-1, NFAT, and EGR motifs being the
most abundant occupied motifs (Figs 8E and EV5C and D). This
result is consistent with the notion that iDHSs are enriched in motifs
occupied by multiple species of inducible TFs, responding to concur-
rent signals. Examples of AP-1 and AP-1/NFAT FPs are shown here
for the 15-kb and 35-kb DHSs at the Ccl1 locus. In this instance,
the 35-kb DHS represented a preexisting DHS which recruited
AP-1 and became a broader DHS after stimulation. Overall, our
analyses identified a strong trend toward a significant difference in
the binding motif composition between pDHSs and iDHSs.
The above studies revealed that the iDHSs and pDHSs bind a
common set of inducible and constitutively expressed transcription
factors yet exhibit different kinetic behaviors within chromatin with
one class of binding sites being maintained but not the other. To
further investigate the reason for this difference, we determined the
number of motifs per DHS within the most enriched population of
each class of DHSs. For this purpose, we compared the most specific
subset of 1,217 iDHSs with the 2,882 pDHSs identified in TM. To
further validate TB as a surrogate model for TM, we also analyzed
the equivalent subset of the 3,085 most enriched DHSs detected in a
comparison of TB and TN (Fig 9A and B), as these should give the
same pattern as TM. As expected, the TM- and TB-specific DHSs had
an essentially identical motif composition, with RUNX, ETS, and
STAT motifs being abundant, whereas NFAT and AP-1 motifs were
more frequent in iDHSs (Fig 9A). We tabulated the motif counts for
each dataset for the 5 most abundant motifs for inducible factors
(AP-1, NFAT, EGR, NF-jB, and CREB/ATF) and the 5 most abun-
dant motifs for constitutive factors (ETS, RUNX, KLF, GATA, and
E-box) (Fig 9B). The motifs used for this purpose were the ones iden-
tified as de novo motifs by HOMER above (Dataset EV5). An analysis
of the ChIP peaks confirmed that ETS-1 and RUNX1 were each
bound to two-third of 2,882 pDHSs (Fig 9C). Overall, these analyses
revealed that TM- and TB-specific pDHSs contained three times more
motifs for constitutive than inducible factors and the converse was
true for iDHSs with the ratio of inducible versus constitutive factor
binding sites being two to one. Moreover, the comparison of co-
localizing motifs within pDHSs and iDHSs showed a strong co-
localization between inducible and constitutive factor binding sites in
pDHSs, but not in iDHSs (Figs 6A and EV5A). These different motif
compositions are exemplified by the +9-kb pDHS and the +6.5-kb
iDHS at the Syne3 locus, the Th2 LCR, and the Cxcr3 locus
(Appendix Fig S6). In the Syne3 +9-kb pDHS, there is also an exam-
ple of a composite ETS/RUNX motif of the type shown in Fig 5A.
Taken together, these data suggest a model whereby the balance
of a common set of factors at specific cis-elements determines the
kinetic behavior of transcription factor assembly and maintenance,
and nucleosome occupancy (Fig 9D). This finding supports a model
whereby the acquisition of immunological memory in T cells is
driven during blast cell transformation by inducible factors that
enable the redistribution of preexisting factors. The key to this
model is that the density of constitutive factors bound at pDHSs is
sufficient to maintain them in the long term, once they have formed,
but is insufficient to initially create these DHSs without additional
support from inducible factors. The converse is true of the inducible
DHSs, which use a high density of inducible motifs to function as
rapid response elements, and cannot be maintained once the induc-
ing stimulus is removed. In addition, there will be many other DHSs
which share some of the properties of both pDHSs and iDHSs.
Discussion
This study significantly advances our understanding of the funda-
mental molecular mechanisms that underpin the long-term mainte-
nance of stable molecular memory in cells that have previously
responded to transient stimuli. In our model, inducible factors acti-
vated by the primary response in naı¨ve T cells direct the re-localization
of the preexisting factors ETS-1 and RUNX1 to thousands of newly
established pDHSs which remain associated with pDHSs and
continue to modify chromatin structure after the initial stimulation
has ceased. Their binding is likely to be further stabilized due to the
fact that the ETS motif identified in Fig 5A is a composite ETS/
RUNX motif binding these factors cooperatively (Hollenhorst et al,
2009). Based on the functional and correlative studies described
here, many of these pDHSs are not typically classical enhancers, but
function at close range to maintain a regional state of active chro-
matin in the absence of stimulation and increase the accessibility of
inducible enhancers to the factors that direct the immunological
◀ Figure 7. Motifs for constitutive TFs are footprinted in vivo in pDHSs.A Enriched motifs defined by HOMER using a de novo motif search of the digital DNase I FPs identified in the pDHSs in TB.
B DNase I cleavage patterns in TB from the FPs determined by Wellington at the pDHSs centered on the motif named at the top and ordered according to increasing FP
occupancy score. Left: Cuts are shown within a 200-bp window with positive (red) and negative (green) strand imbalances in DNase I cuts. Right: Average profiles of
the actual DNase I cuts at footprinted motifs within the pDHSs, with upper strand DNA cuts shown in red and lower strand cuts in blue.
C Average profiles of the DNase I cuts at footprinted motifs within the pDHSs in TM determined as in (B).
D Example of FP patterns and motifs at the 3.7-kb and 35-kb pDHSs at the Ccl1 locus in TB.
E mRNA array values for Ccl1 expression.
F Luciferase reporter gene assays in stimulated Jurkat T cells performed as in Fig 1H of the IL3 promoter alone or in combination with the Ccl1 3.7-kb or 35-kb DHSs,
with SD. Values are expressed as the mean with the number of replicates for each (n) shown underneath.
G Footprinting of AP-1 sites in TB
+. DNase I upper and lower strand cleavage patterns were calculated as in (B) (left) plus the average DNase I profiles (right) for all AP-1
motifs within the subset of 2,882 defined pDHSs in TB cells before and after stimulation, ranked in order of decreasing FP probability score.
H Distribution of the FP probability scores for the data shown in (G).
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recall response. Significantly, the chromatin of inducible enhancers
linked to pDHSs in TM and TB is inaccessible in TN, and these
elements therefore fail to respond efficiently to the same stimuli. In
support of the idea of a facilitator role for pDHSs, we demonstrate a
tight correlation between the preferential induction of genes in
previously activated T cells and the close proximity of (i) pDHSs to
iDHSs, and (ii) iDHSs to the TSSs of these inducible genes. Signifi-
cantly, the presence or absence pDHSs has little impact on
steady-state transcription of nearby genes, in contrast to classical
enhancers. Others have also recently observed that evidence of TF
binding is a much more reliable guide to enhancer function than the
mere presence of open chromatin or active histone modifications
(Kwasnieski et al, 2014; Dogan et al, 2015). Given that just 11% of these
modified regions tested had strong enhancer activity (Kwasnieski
et al, 2014), it is evident that there is a growing need to define
distinct classes of distal regulatory element.
Our data also provide a valuable resource defining all potential
inducible enhancers in T cells, plus the factors required for their
activation. The mechanisms driving inducible gene expression in
activated T cells have been well defined at numerous individual
loci, including the cytokine genes described above. This typically
involves the induction of NFAT, AP-1, and NF-jB by TCR signaling
pathways, which in turn mediate the induction of DHSs at promot-
ers and enhancers, and the activation of mRNA expression. Here we
show that one-third of all iDHSs utilize composite NFAT/AP-1
elements where NFAT and AP-1 are known to bind cooperatively.
We previously reported on such a mechanism for the CSF2 locus
(Cockerill et al, 1995; Johnson et al, 2004), and in the current study,
we defined the consensus sequence underpinning the cooperative
binding of NFAT and AP-1 for the full complement of iDHSs.
Furthermore, our study provides a firm basis for why these enhan-
cers at iDHSs are non-functional in TN, even though TN efficiently
express NFAT and AP-1 upon activation, simply by virtue of their
chromatin being inaccessible.
Intriguingly, pDHSs and iDHSs utilize essentially the same set of
TFs, yet they behave in very different ways. We provide convincing
global evidence that the difference in the ratios of constitutive to
inducible TF motifs distinguishes these two classes of regulatory
element and accounts for their properties. The low density of indu-
cible TF motifs in pDHSs correlates with a requirement for extensive
exposure to TCR signaling during blast cell transformation before
the chromatin encompassing these elements is rendered accessible.
However, once activated via such a hit-and-run mechanism, their
high density of constitutive TF motifs allows them to remain acces-
sible. Conversely, the high density of inducible TF motifs plus low
density of constitutive TF motifs in iDHSs ensures their tight regula-
tion whereby they are rapidly induced, but readily become reoccu-
pied by nucleosomes once the stimulus is removed.
Previous studies have found that a subset of DHSs, and a subset
of the TFs bound to these DHSs, can be maintained during mitosis
(Martinez-Balbas et al, 1995; Kadauke et al, 2012; Hsiung et al,
2015). These studies defined GATA-1 as a mitotic bookmarking
factor. However, these studies also found that the majority of mitoti-
cally preserved DHSs were localized at promoters, whereas the
majority of the distal DHSs which include enhancers were erased.
The fact that pDHSs are maintained during multiple rounds of cell
division suggests that pDHSs may form a class of distal elements
that can, unlike most enhancers, maintain accessible chromatin
during mitosis. This is made more likely by the fact that pDHSs bind
co-localizing, constitutively expressed TFs such as RUNX1 and ETS-1
which can bind in a concerted fashion to composite ETS/RUNX
elements (Hollenhorst et al, 2009). In this context, it is interesting
to note that all members of the RUNX transcription factor family
have been shown to associate with mitotic chromatin (Young et al,
2007; Bakshi et al, 2008; Pande et al, 2009). Transcription factor
complexes recruit chromatin modifiers and chromatin regions
flanking pDHSs are marked by the active modifications H3K4me2
and H3K27ac, which can attract chromatin additional modifying
complexes containing PHD domain or Bromo domains. We show
here that pDHSs bind the co-activator BRD4 whose binding is also
maintained during mitosis (Zhao et al, 2011). We propose, there-
fore, that pDHSs contain stable transcription factor complexes that
keep such elements nucleosome-free during cell division, thus
creating a looser and more dynamic chromatin structure which (i)
allows the re-assembly of the full complex after cell division and
(ii) exposes more of the chromatin-bound DNA to the inducible
TFs searching for their binding sites.
Our current work also increases our understanding of the tightly
regulated context-dependent expression of key immunological regu-
lators in differentiated T cells, such as Il4 in Th2 cells and Cxcr3 in
Th1 cells. When first activated in uncommitted TN, both genes
make use of a similar set of TFs to establish specific pDHSs and
iDHSs. However, their pDHSs differ with respect to the additional
GATA and T-box motifs present, allowing them to exist in an acces-
sible state ready to respond to alternate additional signals. In this
way, unpolarized TB are able to respond to either GATA-3 binding
to the Th2 LCR GATA motifs, or TBX21 binding to T-box motifs in
the Cxcr3 3-kb pDHS, dependent upon which Th2 or Th1 differen-
tiation-inducing signals they subsequently encounter. We propose,
therefore, that the acquisition of pDHSs represents a form of chro-
matin imprinting used universally across all classes of T cells when
they are first activated, irrespective of whether they are CD4 or CD8
T cells, and independent of subsequent differentiation decisions.
Others have also predicted a role for regions of chromatin marked
by H3K4me2 in supporting gene activation in Th1 and Th2 cells
(Seumois et al, 2014), but the mechanism by which such patterns
were established was unclear. The mechanisms described here may
also help to account for the origins of a class of preexisting DHSs
which are present in activated T cells and recruit FOXP3 during the
course of regulatory T-cell differentiation (Samstein et al, 2012).
Taken together, this body of evidence supports the emerging view
that the critical steps in establishing immunological memory do
indeed occur early during the initial stages of naı¨ve T-cell activa-
tion, and not during the subsequent differentiation stages when
additional cell type-specific TFs get recruited (Badovinac et al,
2005; Kedzierska et al, 2007; Russ et al, 2014; Crompton et al,
2015).
Last, but not least, our work explains previous studies demon-
strating differences in the distribution of activating and repressive
chromatin marks in TN and TM (Rothenberg & Zhang, 2012) and
provides the likely regulatory mechanisms underlying these
patterns. A recent study found that a lower level of DNA methyla-
tion in the TM was generally associated with a higher level of induc-
tion upon stimulation (Komori et al, 2015). There is also evidence
linking loss of the repressive H3K27me3 modification with gene
activation in effector T cells (Araki et al, 2009). However, not all
ª 2016 The Authors The EMBO Journal
Sarah L Bevington et al T-cell activation leads to epigenetic priming The EMBO Journal
17
D0
0.2
0.4
0.6
0.8
1
1.2
RUNX1 ETS STAT5 AP-1 NFAT
2882 memory 3085 blast 1217 iDHS
A B
0.00
0.50
1.00
1.50
2.00
2.50
2882 memory 3085 blast 1217 iDHS
Constitutive Inducible
M
ot
ifs
 p
er
 D
H
S
Motifs enriched within TM, TB and TB+ DHSs Constitutive vs Inducible factor motifs
within TM, TB and TB+ DHSs
S
H
D rep sfito
M
C ETS-1 ChIP peaks
65%
RUNX1 ChIP peaks
69%
TN TB TN TBpDHSs pDHSs pDHSs pDHSs
Figure 9. Composition and properties of pDHSs and iDHSs.
A Motif counts for abundant TF binding sites at the specific DHSs in TM, TB, and TB
+.
B Total motif counts for 5 inducible motifs (AP-1, NFAT, EGR, NF-jB, and CREB/ATF) and 5 constitutive motifs (ETS, RUNX, KLF, GATA, and E-box) in the specific DHSs in
TM, TB, and TB
+. The motifs used here are defined in Dataset EV5.
C Overlaps between ETS-1 and RUNX1 ChIP peaks and the 2,882 pDHSs in TN compared to TB.
D Mechanisms of pDHS and iDHS regulation in T cells.
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inducible TM-specific genes are marked by higher levels of
H3K27me3 or DNA methylation in TN prior to TCR activation
(Mirabella et al, 2010; Zediak et al, 2011). These modifications cannot,
therefore, be solely responsible for the silent gene state in the naive
T cells. Our study now suggests that there are at least two parallel
modes of regulation controlling the establishment of the gene
expression program in memory T cells: one involving the loss of
H3K27me3 and gain of H3K4me3, primarily at promoters, and an
additional one involving the de novo activation of a separate set of
predominantly distal regulatory elements associated with H3K4me2.
In the case of inducible genes, our data suggest that it is not primar-
ily loss of repressive modifications in naı¨ve cells that accounts for
the memory recall effect in memory T cells. Rather, it is the intrinsic
inaccessibility of inactive compact chromatin in TN and the gain of
active modifications to increase accessibility in TB and TN that
makes gene reactivation a much more efficient process. We present
this here as a fundamental mechanism that has the potential to
ensure the tight regulation of the immune system (Fig 9D), which is
likely to play a major role in the acquisition of immunological
memory in T cells and which places the accessibility of chromatin to
the binding of transcriptional regulators into the heart of this process.
Materials and Methods
Detailed methods are available in the Supplementary Methods in the
Appendix.
Mice
C42 transgenic mice containing a 130-kb AgeI genomic DNA frag-
ment of the human IL3/CSF2 locus on a C57BL/6J background were
described previously (Mirabella et al, 2010). Studies involving these
mice were approved by the ethically reviewed U.K. Home Office
animal license PPL 40/3086.
Cell culture and purification
TN and TM were isolated and purified using MACS (Miltenyi)
and Easy Sep (Stem Cell Technologies) purification kits (see
Appendix Supplementary Methods). TB were generated from
purified TN cultured at 5 × 10
5 cells/ml in IMDM and activated
with 2 lg/ml concanavalin A for 40 h. Cells were maintained at
5 × 105 cells/ml in 50 U/ml IL-2 (Peprotech) for an additional
2–3 days before harvesting. Cells were stimulated with 20 ng/ml
phorbol myristate acetate (PMA) and 2 lM calcium ionophore
(I) for up to 4 h.
DNase I-hypersensitive site analysis
DNase I digestion assays were carried out as previously described
(Bert et al, 2007). A more detailed protocol is available in the
Appendix Supplementary Methods.
Chromatin immunoprecipitation
ChIP for the H3K4me2 and H3K27ac antibodies was carried out as
previously described (Lichtinger et al, 2012). For all other antibodies,
chromatin was prepared and immunoprecipitated as described in
the Supplementary Methods in the Appendix.
mRNA expression analyses
Total RNA was extracted from cells using TRIzol (Invitrogen). RNA
was either (i) reverse-transcribed to cDNA using M-MLV Reverse
Transcriptase (Invitrogen) for analysis by quantitative PCR or (ii)
prepared for microarray analysis (Supplementary Methods in the
Appendix).
Library preparation
DNA libraries for sequencing were prepared from ~10 ng DNA from
DNase I or ChIP samples. Libraries for DNase-Seq of untreated CD4
and CD8 TN and TB were prepared for sequencing on the SOLiD
TM
platform according to the manufacturer’s instructions (Applied
Biosystems). All other libraries were prepared using the Tru-Seq
library preparation kit according to the manufacturer’s instructions
(Illumina).
Bioinformatics and data analysis
Detailed data analysis is provided in the Supplementary Methods in
the Appendix.
Accession numbers
ChIP-Seq, DNase-Seq, and expression microarray datasets have been
deposited on the Gene Expression Omnibus (GEO) as a super series
under GEO accession number GSE67465. Individual datasets were
deposited as follows: ChIP-Seq under accession number GSE67443,
DNase-Seq under accession number GSE67451, and expression
microarrays under accession number GSE67464.
Public datasets
H3K27me3 ChIP-Seq datasets in naı¨ve CD4 T cells [(Wei et al,
2009), GEO accession number GSM361998], naı¨ve, effector,
memory CD8 T cells [(Russ et al, 2014), SRA accession numbers
SRX793474, SRX793485, respectively], Th2 cells [(Wei et al, 2009),
GEO accession number GSM362002], as well as ENCODE Jurkat
DNaseI-Seq [(Thurman et al, 2012), GEO accession number
GSM736501], and H3K27ac in naı¨ve CD4 T cells [(Lara-Astiaso et al,
2014), GEO accession number GSM1441281] were retrieved,
aligned, and processed as described above and selected for viewing
using the UCSC Genome Browser.
Expanded View for this article is available online.
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